New hope for colorectal cancer patients who run out of options
NCT ID NCT05990543
Summary
This study is testing whether combining two drugs, nelmastobart and capecitabine, is safe and effective for people with advanced colorectal cancer that has spread or returned. It's specifically for patients whose cancer has stopped responding to or who cannot tolerate two common chemotherapy drugs. The trial will first find the safest dose, then see how well the combination works at controlling the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OR METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Korea University Medical Center 73, Goryeodae-ro, Seongbuk-gu
Seoul, Seoul, 02841, South Korea
Conditions
Explore the condition pages connected to this study.